A cross-sectional study showed that the percentage of circulating CD8+ T cells was correlated with albuminuria in T2DM, indicating that systemic inhibition of T lymphocytes provides a new therapeutic direction for albuminuria in DKD (184). This evidence concerns the gene CD8A and type 2 diabetes mellitus.